Image by Jessica DeWinter via Flickr
“Stem cells are no longer only the future of aesthetic surgery, they are the present,” said Alessandro Gennai, an associate plastic surgeon at the European Academy of Facial Plastic Surgery (EAFPS). For the past year, Gennai has been using a modified technique used to preserve stem cells in lipofilling procedures. “I have already performed numerous operations, with excellent results and without side-effects,” said the surgeon from Bologna, “therefore I can say that lipofilling is the best solution for someone who wants to eliminate wrinkles before the summer. The procedure lasts 30
Fondazione IRCCS Istituto Nazionale Tumori di Milano
Methods to provide safer stem cell transplants to individuals who are not completely compatible with the donor are being developed. Encouraging results have come from a post-transplant cellular therapy, which strengthens the immune system against viral infections and tumors, developed for the first time at the National Tumor Institute (INT) in Milan. The INT conducted the first phase I-II study in the world, published in ‘Blood’, whose main objective was to assess the use of a low dose radiochemotherapy, followed by low dose post-transplant infusions CD8-depleted donor lymphocytes after
Image via Wikipedia
Scientists at the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa have discovered a powerful new way to stimulate muscle regeneration, paving the way for new treatments for debilitating conditions such as muscular dystrophy.
The research, to be published in the June 5 issue of Cell Stem Cell, shows for the first time that a protein called Wnt7a increases the number of stem cells in muscle tissue, leading to accelerated growth and repair of skeletal muscle.
“This discovery shows us that by targeting stem cells to boost their numbers, we can improve the body’s ability to repair
Image via Wikipedia
Sufferers from the debilitating bowel condition Crohn‘s disease may be cured using a groundbreaking stem cell treatment, according to the British doctor leading the research.
Initial findings from the world’s first controlled trial of the procedure have raised hopes that it could banish the disease’s symptoms for many years in up to half of the patients who undergo it.
The pioneering therapy involves “rebooting” the patient’s immune system, by first destroying the cells that have attacked it to cause the Crohn’s, and then replacing them.
Professor Chris Hawkey, a gastroenterologist at Nottingham University, is leading the Autologous Stem Cell Transplantation
New Technology to Increase Efficacy of Adult Stem Cells in COPD Treatment
Entest BioMedical announced today it has filed a second patent application in the area of Chronic Obstructive Pulmonary Disease (COPD). This new patent application builds upon the Company’s previously filed COPD patent application and involves the use of photoceutical devices to target stem cells toward areas impacted by COPD in the lungs.
Steve Josephs, PhD, a Scientific Advisor to the Company stated “that by using photoceutical devices in treating COPD, it is believed stem cells can be focused on areas of the lungs where there is damage. Furthermore, being